Sterne Kessler’s Matthew Bodenstein and Daniel Choo moderated the KnowledgeBridge Breakout Session titled “Biopharma Patents During the Post-Amgen Era” at the 2025 IP Life Sciences Forum hosted by Consero. The breakout session discussed specification (breadth & support), claim strategy (fate of genus and functional claims), and global coordination (e.g., EPO and China comparisons).
The firm was also a conference sponsor.
Related Professionals
Related Industries
Stay in the Know
Receive insights from the most respected practitioners of IP law, straight to your inbox.
Subscribe for Updates